Cargando…
Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
There is considerable interest and enthusiasm within the clinical gynecologic oncology community regarding the potential for poly (ADP-ribose) polymerase inhibitors to play a critically relevant role in the management of epithelial ovarian cancer and particularly (although not exclusively) in the se...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784554/ https://www.ncbi.nlm.nih.gov/pubmed/29313444 http://dx.doi.org/10.1177/1745505717750694 |